BioLife Solutions Inc. Reports Q2 2026 Results Press Release

What Happened

• On August 6, 2026, BioLife Solutions, Inc. filed a Form 8-K (Item 2.02) to announce unaudited financial results and operational highlights for the quarter ended June 30, 2026. The company furnished a press release as Exhibit 99.1 to the filing. The report was signed by Chief Financial Officer Troy Wichterman.

Key Details

• Filing date: August 6, 2026.
• Quarter covered: Q2 2026 (period ended June 30, 2026).
• Disclosure type: Unaudited financial results and operational highlights announced via press release (Exhibit 99.1).
• Technical exhibit: Cover Page Interactive Data File embedded in the Inline XBRL document (Exhibit 104).

Why It Matters

• This 8-K notifies investors that BioLife has publicly released its quarterly results and business updates; the press release will contain the specific earnings, revenue, cash and operational metrics investors use to evaluate performance. Because the results are unaudited, investors should consult the full press release and subsequent filings (e.g., the quarterly report) for audited details and management commentary. Review the attached Exhibit 99.1 for the actual figures and any forward-looking commentary.